Abstract

Covid-19 and Rhino-Orbital Mucormycosis – A Case Report

Highlights

  • There has been a rapid spread of coronavirus disease (COVID-19) globally [1]

  • In COVID-19 pneumonia, super-infections and coinfections are under exploration [2]

  • Due to the difficulty in diagnosis, mucormycosis adds onto the poor prognosis in such immune suppressed COVID-19 patients

Read more

Summary

Introduction

There has been a rapid spread of coronavirus disease (COVID-19) globally [1]. In influenza, SARS, MERS, and other viral respiratory illnesses secondary infections are a well-described occurrence. In severely ill, hospitalized COVID-19 patients, secondary infections are reportedly common, encompassing between 10 and 30% of cases, fungal being 10 times more common [2]. Earlier, both Aspergillus and Candida have been reported as the main fungal pathogens for co-infection in such cases. Due to the difficulty in diagnosis, mucormycosis adds onto the poor prognosis in such immune suppressed COVID-19 patients. Detailed history was obtained from the patient He was a known case of type 2 Diabetes mellitus, on medications from past 1 year. On serial follow-up, there was gradual improvement in the eye movements of right eye, compared with the normal along with resolution of chemosis

Discussion
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call